nodes	percent_of_prediction	percent_of_DWPC	metapath
Dinoprost Tromethamine—SLCO3A1—Methotrexate—ankylosing spondylitis	0.346	0.508	CbGbCtD
Dinoprost Tromethamine—SLC22A11—Methotrexate—ankylosing spondylitis	0.114	0.167	CbGbCtD
Dinoprost Tromethamine—SLC22A7—Methotrexate—ankylosing spondylitis	0.109	0.16	CbGbCtD
Dinoprost Tromethamine—SLC22A8—Methotrexate—ankylosing spondylitis	0.0665	0.0974	CbGbCtD
Dinoprost Tromethamine—SLC22A6—Methotrexate—ankylosing spondylitis	0.0463	0.0679	CbGbCtD
Dinoprost Tromethamine—TBXA2R—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.0167	0.0841	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.0151	0.0759	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.0113	0.0567	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.0111	0.0559	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.011	0.0555	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Prostanoid ligand receptors—PTGER4—ankylosing spondylitis	0.011	0.0555	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.01	0.0504	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0092	0.0463	CbGpPWpGaD
Dinoprost Tromethamine—Dinoprostone—PTGER4—ankylosing spondylitis	0.00851	1	CrCbGaD
Dinoprost Tromethamine—PTGER3—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0083	0.0417	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.0075	0.0377	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.00734	0.0369	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Eicosanoid ligand-binding receptors—PTGER4—ankylosing spondylitis	0.00734	0.0369	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.0062	0.0312	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.00607	0.0305	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Small Ligand GPCRs—PTGER4—ankylosing spondylitis	0.00607	0.0305	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00576	0.029	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00431	0.0216	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00421	0.0212	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Prostaglandin Synthesis and Regulation—PTGER4—ankylosing spondylitis	0.00421	0.0212	CbGpPWpGaD
Dinoprost Tromethamine—SLCO2A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00203	0.0102	CbGpPWpGaD
Dinoprost Tromethamine—SLCO3A1—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00193	0.00969	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00147	0.0074	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—G alpha (s) signalling events—PTGER4—ankylosing spondylitis	0.00135	0.00681	CbGpPWpGaD
Dinoprost Tromethamine—HPGDS—Aryl Hydrocarbon Receptor—TNF—ankylosing spondylitis	0.00127	0.00637	CbGpPWpGaD
Dinoprost Tromethamine—GALR3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00126	0.00634	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00114	0.00574	CbGpPWpGaD
Dinoprost Tromethamine—Extravasation—Dexamethasone—ankylosing spondylitis	0.00112	0.0101	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Betamethasone—ankylosing spondylitis	0.00112	0.0101	CcSEcCtD
Dinoprost Tromethamine—Hypoxia—Methotrexate—ankylosing spondylitis	0.00112	0.0101	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Triamcinolone—ankylosing spondylitis	0.00107	0.00974	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Methylprednisolone—ankylosing spondylitis	0.00107	0.00971	CcSEcCtD
Dinoprost Tromethamine—Petechiae—Prednisone—ankylosing spondylitis	0.00103	0.00935	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00103	0.00518	CbGpPWpGaD
Dinoprost Tromethamine—Burning sensation—Methotrexate—ankylosing spondylitis	0.00102	0.00925	CcSEcCtD
Dinoprost Tromethamine—SLC22A11—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.00101	0.00509	CbGpPWpGaD
Dinoprost Tromethamine—Cyanosis—Methotrexate—ankylosing spondylitis	0.001	0.00908	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Prednisolone—ankylosing spondylitis	0.000979	0.00888	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000978	0.00492	CbGpPWpGaD
Dinoprost Tromethamine—Diabetes mellitus—Prednisolone—ankylosing spondylitis	0.000974	0.00883	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Betamethasone—ankylosing spondylitis	0.000974	0.00883	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Dexamethasone—ankylosing spondylitis	0.000974	0.00883	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.00096	0.00483	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.00094	0.00473	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac failure congestive—Prednisolone—ankylosing spondylitis	0.000934	0.00847	CcSEcCtD
Dinoprost Tromethamine—SLC22A7—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000919	0.00462	CbGpPWpGaD
Dinoprost Tromethamine—Thrombophlebitis—Triamcinolone—ankylosing spondylitis	0.0009	0.00816	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Methylprednisolone—ankylosing spondylitis	0.000898	0.00815	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Triamcinolone—ankylosing spondylitis	0.000896	0.00812	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Methylprednisolone—ankylosing spondylitis	0.000894	0.00811	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000882	0.00444	CbGpPWpGaD
Dinoprost Tromethamine—Petechiae—Methotrexate—ankylosing spondylitis	0.000861	0.00781	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Triamcinolone—ankylosing spondylitis	0.000859	0.00779	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Methylprednisolone—ankylosing spondylitis	0.000857	0.00778	CcSEcCtD
Dinoprost Tromethamine—Hiccups—Prednisone—ankylosing spondylitis	0.000848	0.00769	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Betamethasone—ankylosing spondylitis	0.000817	0.00741	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Dexamethasone—ankylosing spondylitis	0.000817	0.00741	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Dexamethasone—ankylosing spondylitis	0.000813	0.00737	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Betamethasone—ankylosing spondylitis	0.000813	0.00737	CcSEcCtD
Dinoprost Tromethamine—Extravasation—Methotrexate—ankylosing spondylitis	0.000812	0.00737	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Prednisolone—ankylosing spondylitis	0.000805	0.00731	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Dexamethasone—ankylosing spondylitis	0.000779	0.00707	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Betamethasone—ankylosing spondylitis	0.000779	0.00707	CcSEcCtD
Dinoprost Tromethamine—SLC22A8—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000772	0.00388	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.00077	0.00387	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000754	0.00379	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCRs, Class A Rhodopsin-like—PTGER4—ankylosing spondylitis	0.000754	0.00379	CbGpPWpGaD
Dinoprost Tromethamine—TBXA2R—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000745	0.00374	CbGpPWpGaD
Dinoprost Tromethamine—Cardiac arrest—Triamcinolone—ankylosing spondylitis	0.000741	0.00672	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Methylprednisolone—ankylosing spondylitis	0.000739	0.0067	CcSEcCtD
Dinoprost Tromethamine—Sepsis—Prednisone—ankylosing spondylitis	0.000736	0.00668	CcSEcCtD
Dinoprost Tromethamine—Respiratory failure—Methotrexate—ankylosing spondylitis	0.000722	0.00655	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Prednisone—ankylosing spondylitis	0.000711	0.00645	CcSEcCtD
Dinoprost Tromethamine—Pulmonary embolism—Methotrexate—ankylosing spondylitis	0.000709	0.00643	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Prednisone—ankylosing spondylitis	0.000708	0.00642	CcSEcCtD
Dinoprost Tromethamine—Cardiac failure congestive—Prednisone—ankylosing spondylitis	0.000679	0.00616	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Dexamethasone—ankylosing spondylitis	0.000672	0.0061	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Betamethasone—ankylosing spondylitis	0.000672	0.0061	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000672	0.00338	CbGpPWpGaD
Dinoprost Tromethamine—Bronchospasm—Methylprednisolone—ankylosing spondylitis	0.000661	0.00599	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.00066	0.00332	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000646	0.00325	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Class A/1 (Rhodopsin-like receptors)—PTGER4—ankylosing spondylitis	0.000646	0.00325	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A6—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000645	0.00324	CbGpPWpGaD
Dinoprost Tromethamine—Hypokalaemia—Betamethasone—ankylosing spondylitis	0.000643	0.00584	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Dexamethasone—ankylosing spondylitis	0.000643	0.00584	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000634	0.00319	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Gastrin-CREB signalling pathway via PKC and MAPK—MMP3—ankylosing spondylitis	0.000621	0.00312	CbGpPWpGaD
Dinoprost Tromethamine—Sepsis—Methotrexate—ankylosing spondylitis	0.000615	0.00558	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Prednisolone—ankylosing spondylitis	0.000597	0.00541	CcSEcCtD
Dinoprost Tromethamine—Thrombophlebitis—Methotrexate—ankylosing spondylitis	0.000594	0.00539	CcSEcCtD
Dinoprost Tromethamine—Diabetes mellitus—Methotrexate—ankylosing spondylitis	0.000591	0.00537	CcSEcCtD
Dinoprost Tromethamine—Cardiac arrest—Prednisone—ankylosing spondylitis	0.000585	0.00531	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methylprednisolone—ankylosing spondylitis	0.000574	0.00521	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Triamcinolone—ankylosing spondylitis	0.000566	0.00514	CcSEcCtD
Dinoprost Tromethamine—Hypokalaemia—Prednisone—ankylosing spondylitis	0.00056	0.00508	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Triamcinolone—ankylosing spondylitis	0.000549	0.00498	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Methylprednisolone—ankylosing spondylitis	0.000547	0.00497	CcSEcCtD
Dinoprost Tromethamine—GALR3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000543	0.00273	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Transmembrane transport of small molecules—ANO6—ankylosing spondylitis	0.000537	0.0027	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000502	0.00253	CbGpPWpGaD
Dinoprost Tromethamine—Bradycardia—Dexamethasone—ankylosing spondylitis	0.000498	0.00452	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Betamethasone—ankylosing spondylitis	0.000498	0.00452	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000493	0.00248	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000492	0.00247	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR ligand binding—PTGER4—ankylosing spondylitis	0.000492	0.00247	CbGpPWpGaD
Dinoprost Tromethamine—Angiopathy—Methylprednisolone—ankylosing spondylitis	0.000488	0.00443	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methylprednisolone—ankylosing spondylitis	0.000486	0.00441	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Prednisolone—ankylosing spondylitis	0.000473	0.00429	CcSEcCtD
Dinoprost Tromethamine—Malaise—Prednisolone—ankylosing spondylitis	0.00046	0.00417	CcSEcCtD
Dinoprost Tromethamine—Syncope—Prednisolone—ankylosing spondylitis	0.000457	0.00415	CcSEcCtD
Dinoprost Tromethamine—Back pain—Triamcinolone—ankylosing spondylitis	0.000454	0.00412	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Prednisolone—ankylosing spondylitis	0.000448	0.00407	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Dexamethasone—ankylosing spondylitis	0.000444	0.00402	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Betamethasone—ankylosing spondylitis	0.000444	0.00402	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Prednisolone—ankylosing spondylitis	0.000442	0.00401	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Prednisolone—ankylosing spondylitis	0.00044	0.004	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Triamcinolone—ankylosing spondylitis	0.000435	0.00395	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Methylprednisolone—ankylosing spondylitis	0.000434	0.00394	CcSEcCtD
Dinoprost Tromethamine—Bradycardia—Prednisone—ankylosing spondylitis	0.000434	0.00393	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Metabolism—B3GNT2—ankylosing spondylitis	0.000432	0.00217	CbGpPWpGaD
Dinoprost Tromethamine—Discomfort—Prednisolone—ankylosing spondylitis	0.000429	0.00389	CcSEcCtD
Dinoprost Tromethamine—Malaise—Triamcinolone—ankylosing spondylitis	0.000423	0.00384	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methylprednisolone—ankylosing spondylitis	0.000422	0.00383	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000421	0.00212	CbGpPWpGaD
Dinoprost Tromethamine—Syncope—Triamcinolone—ankylosing spondylitis	0.000421	0.00382	CcSEcCtD
Dinoprost Tromethamine—Syncope—Methylprednisolone—ankylosing spondylitis	0.00042	0.00381	CcSEcCtD
Dinoprost Tromethamine—Dysuria—Methotrexate—ankylosing spondylitis	0.000416	0.00377	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Triamcinolone—ankylosing spondylitis	0.000412	0.00374	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Methylprednisolone—ankylosing spondylitis	0.000411	0.00373	CcSEcCtD
Dinoprost Tromethamine—Shock—Prednisolone—ankylosing spondylitis	0.00041	0.00372	CcSEcCtD
Dinoprost Tromethamine—Cough—Triamcinolone—ankylosing spondylitis	0.000409	0.00371	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Triamcinolone—ankylosing spondylitis	0.000406	0.00369	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Prednisolone—ankylosing spondylitis	0.000406	0.00369	CcSEcCtD
Dinoprost Tromethamine—HPGDS—Integrated Pancreatic Cancer Pathway—TNF—ankylosing spondylitis	0.000406	0.00204	CbGpPWpGaD
Dinoprost Tromethamine—Convulsion—Methylprednisolone—ankylosing spondylitis	0.000406	0.00368	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Triamcinolone—ankylosing spondylitis	0.000405	0.00367	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Methylprednisolone—ankylosing spondylitis	0.000404	0.00367	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Prednisolone—ankylosing spondylitis	0.000402	0.00365	CcSEcCtD
Dinoprost Tromethamine—Drowsiness—Methotrexate—ankylosing spondylitis	0.000396	0.0036	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Dexamethasone—ankylosing spondylitis	0.000395	0.00358	CcSEcCtD
Dinoprost Tromethamine—Ill-defined disorder—Betamethasone—ankylosing spondylitis	0.000395	0.00358	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Triamcinolone—ankylosing spondylitis	0.000395	0.00358	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methylprednisolone—ankylosing spondylitis	0.000394	0.00357	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Prednisone—ankylosing spondylitis	0.000386	0.0035	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Prednisone—ankylosing spondylitis	0.000385	0.00349	CcSEcCtD
Dinoprost Tromethamine—Malaise—Betamethasone—ankylosing spondylitis	0.000384	0.00348	CcSEcCtD
Dinoprost Tromethamine—Malaise—Dexamethasone—ankylosing spondylitis	0.000384	0.00348	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000382	0.00192	CbGpPWpGaD
Dinoprost Tromethamine—Syncope—Betamethasone—ankylosing spondylitis	0.000382	0.00346	CcSEcCtD
Dinoprost Tromethamine—Syncope—Dexamethasone—ankylosing spondylitis	0.000382	0.00346	CcSEcCtD
Dinoprost Tromethamine—Infection—Triamcinolone—ankylosing spondylitis	0.00038	0.00345	CcSEcCtD
Dinoprost Tromethamine—Sweating—Methotrexate—ankylosing spondylitis	0.00038	0.00345	CcSEcCtD
Dinoprost Tromethamine—PTGER3—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.00038	0.00191	CbGpPWpGaD
Dinoprost Tromethamine—Infection—Methylprednisolone—ankylosing spondylitis	0.00038	0.00344	CcSEcCtD
Dinoprost Tromethamine—Haematuria—Methotrexate—ankylosing spondylitis	0.000378	0.00343	CcSEcCtD
Dinoprost Tromethamine—Shock—Triamcinolone—ankylosing spondylitis	0.000377	0.00342	CcSEcCtD
Dinoprost Tromethamine—Shock—Methylprednisolone—ankylosing spondylitis	0.000376	0.00341	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Betamethasone—ankylosing spondylitis	0.000374	0.00339	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Dexamethasone—ankylosing spondylitis	0.000374	0.00339	CcSEcCtD
Dinoprost Tromethamine—Epistaxis—Methotrexate—ankylosing spondylitis	0.000374	0.00339	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Prednisolone—ankylosing spondylitis	0.000374	0.00339	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Triamcinolone—ankylosing spondylitis	0.000374	0.00339	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Methylprednisolone—ankylosing spondylitis	0.000373	0.00338	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Triamcinolone—ankylosing spondylitis	0.00037	0.00336	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Methylprednisolone—ankylosing spondylitis	0.000369	0.00335	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Dexamethasone—ankylosing spondylitis	0.000369	0.00335	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Betamethasone—ankylosing spondylitis	0.000369	0.00335	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Dexamethasone—ankylosing spondylitis	0.000368	0.00333	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Betamethasone—ankylosing spondylitis	0.000368	0.00333	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Dexamethasone—ankylosing spondylitis	0.000358	0.00325	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Betamethasone—ankylosing spondylitis	0.000358	0.00325	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methylprednisolone—ankylosing spondylitis	0.000357	0.00324	CcSEcCtD
Dinoprost Tromethamine—Pain—Prednisolone—ankylosing spondylitis	0.000356	0.00323	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000351	0.00176	CbGpPWpGaD
Dinoprost Tromethamine—Infection—Betamethasone—ankylosing spondylitis	0.000345	0.00313	CcSEcCtD
Dinoprost Tromethamine—Infection—Dexamethasone—ankylosing spondylitis	0.000345	0.00313	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000345	0.00173	CbGpPWpGaD
Dinoprost Tromethamine—Ill-defined disorder—Prednisone—ankylosing spondylitis	0.000344	0.00312	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Triamcinolone—ankylosing spondylitis	0.000344	0.00312	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Prednisolone—ankylosing spondylitis	0.000343	0.00311	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methylprednisolone—ankylosing spondylitis	0.000343	0.00311	CcSEcCtD
Dinoprost Tromethamine—Shock—Dexamethasone—ankylosing spondylitis	0.000342	0.0031	CcSEcCtD
Dinoprost Tromethamine—Shock—Betamethasone—ankylosing spondylitis	0.000342	0.0031	CcSEcCtD
Dinoprost Tromethamine—Dyspnoea—Triamcinolone—ankylosing spondylitis	0.000341	0.0031	CcSEcCtD
Dinoprost Tromethamine—Agitation—Prednisone—ankylosing spondylitis	0.000341	0.00309	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Dexamethasone—ankylosing spondylitis	0.000339	0.00308	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Betamethasone—ankylosing spondylitis	0.000339	0.00308	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Betamethasone—ankylosing spondylitis	0.000336	0.00305	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Dexamethasone—ankylosing spondylitis	0.000336	0.00305	CcSEcCtD
Dinoprost Tromethamine—Malaise—Prednisone—ankylosing spondylitis	0.000334	0.00303	CcSEcCtD
Dinoprost Tromethamine—Syncope—Prednisone—ankylosing spondylitis	0.000332	0.00302	CcSEcCtD
Dinoprost Tromethamine—Pain—Triamcinolone—ankylosing spondylitis	0.000327	0.00297	CcSEcCtD
Dinoprost Tromethamine—Loss of consciousness—Prednisone—ankylosing spondylitis	0.000326	0.00296	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Betamethasone—ankylosing spondylitis	0.000325	0.00294	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Dexamethasone—ankylosing spondylitis	0.000325	0.00294	CcSEcCtD
Dinoprost Tromethamine—Angiopathy—Methotrexate—ankylosing spondylitis	0.000323	0.00293	CcSEcCtD
Dinoprost Tromethamine—Immune system disorder—Methotrexate—ankylosing spondylitis	0.000321	0.00292	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Prednisone—ankylosing spondylitis	0.000321	0.00291	CcSEcCtD
Dinoprost Tromethamine—Hypertension—Prednisone—ankylosing spondylitis	0.00032	0.0029	CcSEcCtD
Dinoprost Tromethamine—Chills—Methotrexate—ankylosing spondylitis	0.000319	0.0029	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Triamcinolone—ankylosing spondylitis	0.000316	0.00286	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methylprednisolone—ankylosing spondylitis	0.000315	0.00286	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methylprednisolone—ankylosing spondylitis	0.000312	0.00283	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Betamethasone—ankylosing spondylitis	0.000312	0.00283	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Dexamethasone—ankylosing spondylitis	0.000312	0.00283	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Prednisone—ankylosing spondylitis	0.000312	0.00283	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Prednisolone—ankylosing spondylitis	0.000307	0.00278	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Triamcinolone—ankylosing spondylitis	0.000303	0.00275	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methylprednisolone—ankylosing spondylitis	0.000302	0.00274	CcSEcCtD
Dinoprost Tromethamine—Infection—Prednisone—ankylosing spondylitis	0.000301	0.00273	CcSEcCtD
Dinoprost Tromethamine—Back pain—Methotrexate—ankylosing spondylitis	0.0003	0.00272	CcSEcCtD
Dinoprost Tromethamine—Shock—Prednisone—ankylosing spondylitis	0.000298	0.0027	CcSEcCtD
Dinoprost Tromethamine—Pain—Dexamethasone—ankylosing spondylitis	0.000297	0.00269	CcSEcCtD
Dinoprost Tromethamine—Pain—Betamethasone—ankylosing spondylitis	0.000297	0.00269	CcSEcCtD
Dinoprost Tromethamine—Tachycardia—Prednisone—ankylosing spondylitis	0.000295	0.00268	CcSEcCtD
Dinoprost Tromethamine—Hyperhidrosis—Prednisone—ankylosing spondylitis	0.000292	0.00265	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000291	0.00146	CbGpPWpGaD
Dinoprost Tromethamine—Ill-defined disorder—Methotrexate—ankylosing spondylitis	0.000287	0.00261	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Dexamethasone—ankylosing spondylitis	0.000286	0.0026	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Betamethasone—ankylosing spondylitis	0.000286	0.0026	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Betamethasone—ankylosing spondylitis	0.000284	0.00258	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Dexamethasone—ankylosing spondylitis	0.000284	0.00258	CcSEcCtD
Dinoprost Tromethamine—PTGFR—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000284	0.00143	CbGpPWpGaD
Dinoprost Tromethamine—Hypersensitivity—Triamcinolone—ankylosing spondylitis	0.000282	0.00256	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methylprednisolone—ankylosing spondylitis	0.000281	0.00255	CcSEcCtD
Dinoprost Tromethamine—Malaise—Methotrexate—ankylosing spondylitis	0.000279	0.00253	CcSEcCtD
Dinoprost Tromethamine—PTGIR—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000278	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—GPCR downstream signaling—PTGER4—ankylosing spondylitis	0.000278	0.0014	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Prednisolone—ankylosing spondylitis	0.000275	0.0025	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Triamcinolone—ankylosing spondylitis	0.000275	0.00249	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Betamethasone—ankylosing spondylitis	0.000275	0.00249	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Betamethasone—ankylosing spondylitis	0.000275	0.00249	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Dexamethasone—ankylosing spondylitis	0.000275	0.00249	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Dexamethasone—ankylosing spondylitis	0.000275	0.00249	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Methylprednisolone—ankylosing spondylitis	0.000274	0.00249	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000272	0.00137	CbGpPWpGaD
Dinoprost Tromethamine—Paraesthesia—Prednisone—ankylosing spondylitis	0.000272	0.00246	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Triamcinolone—ankylosing spondylitis	0.000271	0.00246	CcSEcCtD
Dinoprost Tromethamine—Cough—Methotrexate—ankylosing spondylitis	0.00027	0.00245	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Methylprednisolone—ankylosing spondylitis	0.00027	0.00245	CcSEcCtD
Dinoprost Tromethamine—Convulsion—Methotrexate—ankylosing spondylitis	0.000268	0.00244	CcSEcCtD
Dinoprost Tromethamine—Chest pain—Methotrexate—ankylosing spondylitis	0.000264	0.00239	CcSEcCtD
Dinoprost Tromethamine—Rash—Prednisolone—ankylosing spondylitis	0.000263	0.00238	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Prednisolone—ankylosing spondylitis	0.000262	0.00238	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methylprednisolone—ankylosing spondylitis	0.000261	0.00237	CcSEcCtD
Dinoprost Tromethamine—Headache—Prednisolone—ankylosing spondylitis	0.000261	0.00237	CcSEcCtD
Dinoprost Tromethamine—Discomfort—Methotrexate—ankylosing spondylitis	0.000261	0.00236	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000258	0.0013	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Triamcinolone—ankylosing spondylitis	0.000253	0.0023	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Methylprednisolone—ankylosing spondylitis	0.000253	0.00229	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000252	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—PTGER4—ankylosing spondylitis	0.000252	0.00127	CbGpPWpGaD
Dinoprost Tromethamine—Infection—Methotrexate—ankylosing spondylitis	0.000251	0.00228	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Prednisone—ankylosing spondylitis	0.000249	0.00226	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Betamethasone—ankylosing spondylitis	0.000249	0.00226	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Dexamethasone—ankylosing spondylitis	0.000249	0.00226	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Prednisone—ankylosing spondylitis	0.000247	0.00224	CcSEcCtD
Dinoprost Tromethamine—Nausea—Prednisolone—ankylosing spondylitis	0.000247	0.00224	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Dexamethasone—ankylosing spondylitis	0.000246	0.00223	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Betamethasone—ankylosing spondylitis	0.000246	0.00223	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000245	0.00123	CbGpPWpGaD
Dinoprost Tromethamine—Hyperhidrosis—Methotrexate—ankylosing spondylitis	0.000244	0.00222	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Triamcinolone—ankylosing spondylitis	0.000243	0.00221	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Methylprednisolone—ankylosing spondylitis	0.000243	0.0022	CcSEcCtD
Dinoprost Tromethamine—Rash—Triamcinolone—ankylosing spondylitis	0.000241	0.00219	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Triamcinolone—ankylosing spondylitis	0.000241	0.00219	CcSEcCtD
Dinoprost Tromethamine—Rash—Methylprednisolone—ankylosing spondylitis	0.000241	0.00219	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methylprednisolone—ankylosing spondylitis	0.000241	0.00218	CcSEcCtD
Dinoprost Tromethamine—Headache—Triamcinolone—ankylosing spondylitis	0.00024	0.00218	CcSEcCtD
Dinoprost Tromethamine—Headache—Methylprednisolone—ankylosing spondylitis	0.000239	0.00217	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Prednisone—ankylosing spondylitis	0.000239	0.00217	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Prednisone—ankylosing spondylitis	0.000239	0.00217	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Betamethasone—ankylosing spondylitis	0.000238	0.00216	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Dexamethasone—ankylosing spondylitis	0.000238	0.00216	CcSEcCtD
Dinoprost Tromethamine—Hypotension—Methotrexate—ankylosing spondylitis	0.000236	0.00214	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Dexamethasone—ankylosing spondylitis	0.00023	0.00208	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Betamethasone—ankylosing spondylitis	0.00023	0.00208	CcSEcCtD
Dinoprost Tromethamine—Nausea—Triamcinolone—ankylosing spondylitis	0.000227	0.00206	CcSEcCtD
Dinoprost Tromethamine—Paraesthesia—Methotrexate—ankylosing spondylitis	0.000227	0.00206	CcSEcCtD
Dinoprost Tromethamine—Nausea—Methylprednisolone—ankylosing spondylitis	0.000227	0.00206	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000226	0.00114	CbGpPWpGaD
Dinoprost Tromethamine—Dyspnoea—Methotrexate—ankylosing spondylitis	0.000225	0.00204	CcSEcCtD
Dinoprost Tromethamine—Somnolence—Methotrexate—ankylosing spondylitis	0.000225	0.00204	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Prednisone—ankylosing spondylitis	0.000223	0.00202	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Dexamethasone—ankylosing spondylitis	0.000221	0.002	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Betamethasone—ankylosing spondylitis	0.000221	0.002	CcSEcCtD
Dinoprost Tromethamine—Rash—Dexamethasone—ankylosing spondylitis	0.000219	0.00199	CcSEcCtD
Dinoprost Tromethamine—Rash—Betamethasone—ankylosing spondylitis	0.000219	0.00199	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Dexamethasone—ankylosing spondylitis	0.000219	0.00199	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Betamethasone—ankylosing spondylitis	0.000219	0.00199	CcSEcCtD
Dinoprost Tromethamine—Headache—Betamethasone—ankylosing spondylitis	0.000218	0.00197	CcSEcCtD
Dinoprost Tromethamine—Headache—Dexamethasone—ankylosing spondylitis	0.000218	0.00197	CcSEcCtD
Dinoprost Tromethamine—Asthenia—Prednisone—ankylosing spondylitis	0.000217	0.00197	CcSEcCtD
Dinoprost Tromethamine—Pain—Methotrexate—ankylosing spondylitis	0.000216	0.00196	CcSEcCtD
Dinoprost Tromethamine—Pruritus—Prednisone—ankylosing spondylitis	0.000214	0.00194	CcSEcCtD
Dinoprost Tromethamine—Feeling abnormal—Methotrexate—ankylosing spondylitis	0.000208	0.00189	CcSEcCtD
Dinoprost Tromethamine—GALR3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000207	0.00104	CbGpPWpGaD
Dinoprost Tromethamine—Diarrhoea—Prednisone—ankylosing spondylitis	0.000207	0.00188	CcSEcCtD
Dinoprost Tromethamine—Gastrointestinal pain—Methotrexate—ankylosing spondylitis	0.000207	0.00188	CcSEcCtD
Dinoprost Tromethamine—Nausea—Dexamethasone—ankylosing spondylitis	0.000206	0.00187	CcSEcCtD
Dinoprost Tromethamine—Nausea—Betamethasone—ankylosing spondylitis	0.000206	0.00187	CcSEcCtD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000204	0.00102	CbGpPWpGaD
Dinoprost Tromethamine—Dizziness—Prednisone—ankylosing spondylitis	0.0002	0.00181	CcSEcCtD
Dinoprost Tromethamine—Abdominal pain—Methotrexate—ankylosing spondylitis	0.0002	0.00181	CcSEcCtD
Dinoprost Tromethamine—Body temperature increased—Methotrexate—ankylosing spondylitis	0.0002	0.00181	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Prednisone—ankylosing spondylitis	0.000192	0.00175	CcSEcCtD
Dinoprost Tromethamine—Rash—Prednisone—ankylosing spondylitis	0.000191	0.00173	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Prednisone—ankylosing spondylitis	0.000191	0.00173	CcSEcCtD
Dinoprost Tromethamine—Headache—Prednisone—ankylosing spondylitis	0.00019	0.00172	CcSEcCtD
Dinoprost Tromethamine—Hypersensitivity—Methotrexate—ankylosing spondylitis	0.000186	0.00169	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling by GPCR—MMP3—ankylosing spondylitis	0.000184	0.000923	CbGpPWpGaD
Dinoprost Tromethamine—Asthenia—Methotrexate—ankylosing spondylitis	0.000181	0.00165	CcSEcCtD
Dinoprost Tromethamine—Nausea—Prednisone—ankylosing spondylitis	0.00018	0.00163	CcSEcCtD
Dinoprost Tromethamine—PTGER1—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00018	0.000903	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling by GPCR—MMP3—ankylosing spondylitis	0.00018	0.000903	CbGpPWpGaD
Dinoprost Tromethamine—Pruritus—Methotrexate—ankylosing spondylitis	0.000179	0.00162	CcSEcCtD
Dinoprost Tromethamine—Diarrhoea—Methotrexate—ankylosing spondylitis	0.000173	0.00157	CcSEcCtD
Dinoprost Tromethamine—Dizziness—Methotrexate—ankylosing spondylitis	0.000167	0.00152	CcSEcCtD
Dinoprost Tromethamine—Vomiting—Methotrexate—ankylosing spondylitis	0.000161	0.00146	CcSEcCtD
Dinoprost Tromethamine—TBXA2R—Signaling Pathways—MMP3—ankylosing spondylitis	0.000161	0.000808	CbGpPWpGaD
Dinoprost Tromethamine—Rash—Methotrexate—ankylosing spondylitis	0.000159	0.00145	CcSEcCtD
Dinoprost Tromethamine—Dermatitis—Methotrexate—ankylosing spondylitis	0.000159	0.00144	CcSEcCtD
Dinoprost Tromethamine—Headache—Methotrexate—ankylosing spondylitis	0.000158	0.00144	CcSEcCtD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000152	0.000766	CbGpPWpGaD
Dinoprost Tromethamine—Nausea—Methotrexate—ankylosing spondylitis	0.00015	0.00136	CcSEcCtD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000149	0.000749	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—PTGER4—ankylosing spondylitis	0.000149	0.000749	CbGpPWpGaD
Dinoprost Tromethamine—PTGER3—Signaling Pathways—MMP3—ankylosing spondylitis	0.000145	0.000729	CbGpPWpGaD
Dinoprost Tromethamine—SLC22A2—Metabolism—B3GNT2—ankylosing spondylitis	0.000112	0.000565	CbGpPWpGaD
Dinoprost Tromethamine—PTGFR—Signaling Pathways—MMP3—ankylosing spondylitis	0.000108	0.000545	CbGpPWpGaD
Dinoprost Tromethamine—PTGIR—Signaling Pathways—MMP3—ankylosing spondylitis	0.000106	0.000534	CbGpPWpGaD
Dinoprost Tromethamine—PTGER1—Signaling Pathways—MMP3—ankylosing spondylitis	0.000106	0.000534	CbGpPWpGaD
